BACKGROUND There have been no improvements in the treatment of metastatic urothelial
cancer in the past several decades. A census of contemporary clinical research in this …

Purpose To endorse the European Association of Urology guideline on muscle-invasive
(MIBC) and metastatic bladder cancer. The American Society of Clinical Oncology (ASCO) …

Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …

Methods All relevant articles on MIBC and metastatic bladder cancer were sought using a
combination of Medline and EMBASE searches. The search strategy involved the following …

Context: Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …

Context We present an overview of the updated 2023 European Association of Urology
(EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To …

Abstract Context The European Association of Urology (EAU) guidelines panel on Muscle-
invasive and Metastatic bladder cancer (BCa) updates its guidelines yearly. This updated …

Objectives: The objectives of this study was (1) to examine the representation of women in
clinical trials for systemic therapy in muscle-invasive (MIBC) or metastatic bladder cancer …

Radical cystectomy is the treatment of choice in localized muscle-invasive urothelial cancer.
Nevertheless, relapses are frequent and systemic chemotherapy has been employed in …